PHARMACOLOGY OF DOPAMINE RELEASE BY AMPHETAMINE
PHARMACOLOGY OF DOPAMINE RELEASE BY AMPHETAMINE
批准号:
7030011
负责人:
MARGARET E GNEGY
金额:
$5.0万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-01 至 2005-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION:(Applicant's Abstract)
Knowledge of factors that regulate the plasmalemma dopamine transporter (DAT)
is crucial to a complete understanding of the actions of several drugs of
abuse. The motor stimulant and reinforcing effects of amphetamine (AMPH) and
methamphetamine (METH), substrates of DAT, are due to their ability to increase
the release of dopamine (DA). AMPHs appear to elicit reverse transport through
DAT by an exchange diffusion mechanism. Our data reveal an unexpected component
in AMPH-mediated reverse transport of DA. We find that AMPH-mediated outward
transport of DA requires protein kinase C (PKC) activity and intracellular
Ca2+. Direct PKC activation mimics the releasing activity of AMPH. The
substrate for the PKC phosphorylation could be the DA transporter itself since
both AMPH and PKC activators elicit phosphorylation of DAT. The focus of this
proposal is to elucidate the mechanism by which PKC exerts its effects on DA
outward transport. The hypothesis to be tested is that AMPH transport activates
PKC which elicits a phosphorylation of DAT that, in turn, enhances outward
transport. The specific aims are:
1. Determine whether DAT agonists other than AMPH increase the phosphorylation
of DAT.
2. Test the hypothesis that an AMPH-mediated phosphorylation of DAT is
responsible for enhanced AMPH-mediated DA release.
3. Determine whether TPA and the AMPH-induced increase in phosphorylation alter
insertion of DAT into the membranes of rat synaptosomes and of hDAT-transfected
cos-7 cells.
4. Test the hypothesis that AMPH increases PKC activity by increasing
translocation of a PKC isozyme proximal to DAT.
Smokable forms of METH are becoming more popular in America, signalling the
start of a new wave of AMPH abuse. Since AMPH is a substrate for DAT, its
mechanism of action is different from that of cocaine, an antagonist. AMPH does
not act at a classical receptor, and the DAT antagonist, cocaine, is also
widely abused. Thus, an ideal inhibitor of AMPH would block its ability to
release DA. A more complete understanding of the mechanism of AMPH action can
lead to a more rational design of inhibitors of the amphetamines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PHARMACOLOGY OF DOPAMINE RELEASE BY AMPHETAMINE
-
批准号:6132577
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
PHOSPHORYLATION IN NEUROADAPTATIONS TO AMPHETAMINES
-
批准号:6523159
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
PHOSPHORYLATION IN NEUROADAPTATIONS TO AMPHETAMINES
-
批准号:6379061
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
PHARMACOLOGY OF DOPAMINE RELEASE BY AMPHETAMINE
-
批准号:6640793
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:7770646
-
项目类别:
-
资助金额:$1.44万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:7847038
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:7281473
-
项目类别:
-
资助金额:$4.8万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:7252438
-
项目类别:
-
资助金额:$42.86万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:7652498
-
项目类别:
-
资助金额:$48.08万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:8635996
-
项目类别:
-
资助金额:$41.98万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:8304611
-
项目类别:
-
资助金额:$49.27万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:7127155
-
项目类别:
-
资助金额:$37.54万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
PHARMACOLOGY OF DOPAMINE RELEASE BY AMPHETAMINE
-
批准号:6515615
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
PHOSPHORYLATION IN NEUROADAPTATIONS TO AMPHETAMINES
-
批准号:6655515
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:7032694
-
项目类别:
-
资助金额:$34.34万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
PHARMACOLOGY OF DOPAMINE RELEASE BY AMPHETAMINE
-
批准号:6378758
-
项目类别:
-
资助金额:$25.26万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:8829211
-
项目类别:
-
资助金额:$41.62万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:9040898
-
项目类别:
-
资助金额:$42.11万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
Pharmacology of Dopamine Release by Amphetamine
-
批准号:8446328
-
项目类别:
-
资助金额:$41.39万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
PHOSPHORYLATION IN NEUROADAPTATIONS TO AMPHETAMINES
-
批准号:6167192
-
项目类别:
-
资助金额:$25.05万
-
财政年份:2000
-
负责人:MARGARET E GNEGY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:张明明
-
依托单位:
钙信号负向调节因子IRBIT抑制肝癌细胞恶性生物学行为的分子机制研究
-
批准号:31960151
-
项目类别:地区科学基金项目
-
资助金额:40.0万元
-
批准年份:2019
-
负责人:徐靖宇
-
依托单位:
基于钙信号特征机制的肿瘤转移调控研究
-
批准号:31970729
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:魏朝亮
-
依托单位:
一种拟南芥IP3结合蛋白作用机制及功能研究
-
批准号:31970723
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2019
-
负责人:韩生成
-
依托单位:
miR-30调控Calcium/Calcineurin通路在慢性肾脏病心肌保护中的作用
-
批准号:81670699
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:郑春霞
-
依托单位:
钙磷基纳米粒子的分布降解及其成骨系细胞响应机制研究
-
批准号:81171682
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:陈大福
-
依托单位:
TRPCs,STIMs及Orais在钙敏感受体介导钙内流及一氧化氮生成中作用和机制研究
-
批准号:31160239
-
项目类别:地区科学基金项目
-
资助金额:53.47万元
-
批准年份:2011
-
负责人:何芳
-
依托单位:
缺氧状况下ATP对血管的调节作用
-
批准号:81041100
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2010
-
负责人:顾雨春
-
依托单位:
水稻OsCAS(Calcium-sensing Receptor)基因的功能分析
-
批准号:30900771
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:赵昕
-
依托单位:
小胶质细胞转核P2X7受体介导的生物学效应的研究
-
批准号:30970918
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2009
-
负责人:向正华
-
依托单位: